USV favors public discussion of investment ideas and early bets on ambitious technology

USV’s representatives said the firm does not treat ideas as secrets to be closely guarded. It tries to put ideas into the world early, sometimes before they are fully developed, to test them and learn from feedback. In their view, public discussion can help surface teams and adjacent opportunities; the firm is also willing to invest early in ideas that seem unusual or even science-fiction-like.

A USV representative cited Doctronics as an example: several years ago, the firm led the company’s seed round when it aimed to put a doctor in people’s pockets. He said the company is now prescribing medicine with AI, a direction that might once have seemed like science fiction.

Discussing the possibility of scientific breakthroughs, USV’s representatives described an approach to early-stage technology investing: imagine a future outcome, assess what technological progress would be needed to reach it, and find a team capable of making the technical breakthrough and commercializing the idea. Farming and construction were mentioned as examples of physical work that could be augmented by intelligence. The representative connected this approach to USV’s recent investment in Generalist. The host also suggested that access to models could enable small teams to make discoveries and commercialize them; the representatives said the subject was top of mind.